Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
10545 | 1054 | 34.2 | 76% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
7 | 4 | INFECTIOUS DISEASES//MICROBIOLOGY//VIROLOGY | 1353914 |
73 | 3 | MICROBIOLOGY//INFECTIOUS DISEASES//STAPHYLOCOCCUS AUREUS | 82747 |
233 | 2 | ACINETOBACTER BAUMANNII//EXTENDED SPECTRUM BETA LACTAMASE//ESBL | 20247 |
10545 | 1 | COLISTIN//POLYMYXIN//COLISTIMETHATE SODIUM | 1054 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | COLISTIN | authKW | 4660226 | 28% | 54% | 298 |
2 | POLYMYXIN | authKW | 1484908 | 10% | 51% | 101 |
3 | COLISTIMETHATE SODIUM | authKW | 446951 | 2% | 86% | 18 |
4 | POLYMYXIN B | authKW | 360336 | 6% | 20% | 63 |
5 | COLISTIMETHATE | authKW | 333995 | 1% | 82% | 14 |
6 | POLYMYXIN E | authKW | 308996 | 2% | 67% | 16 |
7 | IL ANTIINFECT DRUG DEV INNOVAT | address | 276044 | 2% | 53% | 18 |
8 | COLISTIN METHANESULFONATE | authKW | 234650 | 1% | 90% | 9 |
9 | COLISTIN RESISTANCE | authKW | 232377 | 2% | 42% | 19 |
10 | MCR 1 | authKW | 185401 | 1% | 80% | 8 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Microbiology | 14417 | 49% | 0% | 513 |
2 | Infectious Diseases | 11311 | 31% | 0% | 327 |
3 | Pharmacology & Pharmacy | 6577 | 46% | 0% | 488 |
4 | Critical Care Medicine | 331 | 4% | 0% | 40 |
5 | Immunology | 179 | 8% | 0% | 85 |
6 | Chemistry, Analytical | 77 | 5% | 0% | 55 |
7 | Biochemical Research Methods | 40 | 3% | 0% | 32 |
8 | Respiratory System | 38 | 2% | 0% | 23 |
9 | Chemistry, Medicinal | 30 | 2% | 0% | 25 |
10 | Pediatrics | 17 | 2% | 0% | 26 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IL ANTIINFECT DRUG DEV INNOVAT | 276044 | 2% | 53% | 18 |
2 | IL ANTIINFECT DRUG DEV INNOVAT DRUG DELIVERY | 180496 | 1% | 69% | 9 |
3 | IL ANTI INFECT DRUG DEV INNOVAT | 173816 | 1% | 100% | 6 |
4 | MONASH PHARMACEUT SCI | 164917 | 8% | 6% | 89 |
5 | DRUG DELIVERY DISPOSIT DYNAM | 142427 | 3% | 17% | 29 |
6 | ANTIMICROBIAL PHARMACODYNAM | 119173 | 1% | 34% | 12 |
7 | SERV TOXICOL PHARMACOCINET | 94626 | 1% | 47% | 7 |
8 | ICU B | 57939 | 0% | 100% | 2 |
9 | REG MICROBIOL EMERGENCIES | 57939 | 0% | 100% | 2 |
10 | U1070 | 47306 | 1% | 23% | 7 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 37158 | 17% | 1% | 174 |
2 | INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 22048 | 5% | 1% | 54 |
3 | JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 13349 | 7% | 1% | 76 |
4 | EXPERT REVIEW OF ANTI-INFECTIVE THERAPY | 3544 | 1% | 1% | 11 |
5 | JOURNAL OF INFECTION AND CHEMOTHERAPY | 2544 | 1% | 1% | 10 |
6 | ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS | 2289 | 0% | 2% | 5 |
7 | INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 1606 | 1% | 1% | 11 |
8 | CLINICAL MICROBIOLOGY AND INFECTION | 1581 | 1% | 0% | 15 |
9 | ACS INFECTIOUS DISEASES | 1555 | 0% | 2% | 3 |
10 | JOURNAL OF ANTIBIOTICS | 1541 | 2% | 0% | 19 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | COLISTIN | 4660226 | 28% | 54% | 298 | Search COLISTIN | Search COLISTIN |
2 | POLYMYXIN | 1484908 | 10% | 51% | 101 | Search POLYMYXIN | Search POLYMYXIN |
3 | COLISTIMETHATE SODIUM | 446951 | 2% | 86% | 18 | Search COLISTIMETHATE+SODIUM | Search COLISTIMETHATE+SODIUM |
4 | POLYMYXIN B | 360336 | 6% | 20% | 63 | Search POLYMYXIN+B | Search POLYMYXIN+B |
5 | COLISTIMETHATE | 333995 | 1% | 82% | 14 | Search COLISTIMETHATE | Search COLISTIMETHATE |
6 | POLYMYXIN E | 308996 | 2% | 67% | 16 | Search POLYMYXIN+E | Search POLYMYXIN+E |
7 | COLISTIN METHANESULFONATE | 234650 | 1% | 90% | 9 | Search COLISTIN+METHANESULFONATE | Search COLISTIN+METHANESULFONATE |
8 | COLISTIN RESISTANCE | 232377 | 2% | 42% | 19 | Search COLISTIN+RESISTANCE | Search COLISTIN+RESISTANCE |
9 | MCR 1 | 185401 | 1% | 80% | 8 | Search MCR+1 | Search MCR+1 |
10 | COLISTIN SULFATE | 115865 | 1% | 40% | 10 | Search COLISTIN+SULFATE | Search COLISTIN+SULFATE |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | SHAHBAZI, F , DASHTI-KHAVIDAKI, S , (2015) COLISTIN: EFFICACY AND SAFETY IN DIFFERENT POPULATIONS.EXPERT REVIEW OF CLINICAL PHARMACOLOGY. VOL. 8. ISSUE 4. P. 423 -448 | 92 | 90% | 1 |
2 | KELESIDIS, T , FALAGAS, ME , (2015) THE SAFETY OF POLYMYXIN ANTIBIOTICS.EXPERT OPINION ON DRUG SAFETY. VOL. 14. ISSUE 11. P. 1687 -1701 | 79 | 96% | 1 |
3 | FIACCADORI, E , ANTONUCCI, E , MORABITO, S , D'AVOLIO, A , MAGGIORE, U , REGOLISTI, G , (2016) COLISTIN USE IN PATIENTS WITH REDUCED KIDNEY FUNCTION.AMERICAN JOURNAL OF KIDNEY DISEASES. VOL. 68. ISSUE 2. P. 296 -306 | 61 | 94% | 1 |
4 | LEIBOVICI, L , PAUL, M , YAHAV, D , FARBMAN, L , (2012) COLISTIN: NEW LESSONS ON AN OLD ANTIBIOTIC.CLINICAL MICROBIOLOGY AND INFECTION. VOL. 18. ISSUE 1. P. 18 -29 | 76 | 67% | 76 |
5 | ALFAHAD, WA , OMRANI, AS , (2014) UPDATE ON COLISTIN IN CLINICAL PRACTICE.SAUDI MEDICAL JOURNAL. VOL. 35. ISSUE 1. P. 9 -19 | 70 | 91% | 1 |
6 | BISWAS, S , BRUNEL, JM , DUBUS, JC , REYNAUD-GAUBERT, M , ROLAIN, JM , (2012) COLISTIN: AN UPDATE ON THE ANTIBIOTIC OF THE 21ST CENTURY.EXPERT REVIEW OF ANTI-INFECTIVE THERAPY. VOL. 10. ISSUE 8. P. 917 -934 | 95 | 54% | 71 |
7 | BIALVAEI, AZ , KAFIL, HS , (2015) COLISTIN, MECHANISMS AND PREVALENCE OF RESISTANCE.CURRENT MEDICAL RESEARCH AND OPINION. VOL. 31. ISSUE 4. P. 707 -721 | 75 | 63% | 17 |
8 | BERGEN, PJ , LANDERSDORFER, CB , ZHANG, J , ZHAO, M , LEE, HJ , NATION, RL , LI, J , (2012) PHARMACOKINETICS AND PHARMACODYNAMICS OF 'OLD' POLYMYXINS: WHAT IS NEW?.DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE. VOL. 74. ISSUE 3. P. 213-223 | 75 | 71% | 43 |
9 | MONTERO, MM , SALAS, E , LUQUE, S , GRAU, S , BERENGUER, N , HORCAJADA, JP , SORLI, L , (2011) SHEDDING LIGHT ON THE USE OF COLISTIN: STILL GAPS TO BE FILLED.ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA. VOL. 29. ISSUE 4. P. 287 -296 | 68 | 92% | 3 |
10 | LANDMAN, D , GEORGESCU, C , MARTIN, DA , QUALE, J , (2008) POLYMYXINS REVISITED.CLINICAL MICROBIOLOGY REVIEWS. VOL. 21. ISSUE 3. P. 449-465 | 71 | 66% | 203 |
Classes with closest relation at Level 1 |